Market Analysts see Allogene Therapeutics Inc [ALLO] gaining to $5. Time to buy?
Allogene Therapeutics Inc [NASDAQ: ALLO] loss -1.67% on the last trading session, reaching $1.18 price per share at the time. If compared to the average trading volume of 5.53M shares, ALLO reached a trading volume of 7587433 in the most recent trading day, which is